Diabetic Ketoacidosis in Patients with Maturity-Onset Diabetes of the Young

Abstract

Maturity-onset diabetes of the young (MODY) is the most frequent monogenetic diabetes form. It is caused by mutations in genes important for the development and function of pancreatic beta-cells, resulting in impaired insulin secretion capacity. Up to now, 14 different types have been described. The inheritance pattern is autosomal dominant, leading to a strong family history with more than three affected generations. Young age at diagnosis and lack of pancreatic autoantibodies are further characteristics of MODY. The presence of diabetic ketoacidosis (DKA) was long regarded as an exclusion criterion for MODY. However, in recent years, several case reports on MODY patients presenting with DKA have been published. The present study aimed to give an overview of the current knowledge of DKA in MODY patients, with a collection of published case studies as a prerequisite for this review.

Keywords

DKA, ketosis - MODY - HNF4A - HNF1A - HNF1B - NEUROD1 - CEL - PAX4 - INS - ABCC8 - KCNJ11

Publication History

Received: 25 April 2024

Accepted after revision: 30 May 2024

Accepted Manuscript online:
05 June 2024

Article published online:
28 June 2024

• References

• 1 GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023; 402: 203-234
• 2 Emmelheinz M, Knebel B, Müssig K. Diagnose und behandlung des maturity-onset diabetes of the young (MODY). Diabetol Stoffwechs 2021; 16: 378-391
• 3 Hattersley A, Bruining J, Shield J. et al. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2009; 10: 33-42
• 4 Stride A, Vaxillaire M, Tuomi T. et al. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 2002; 45: 427-435
• 5 Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 1975; 24: 44-53
• 6 Pruhova S, Dusatkova P, Neumann D. et al. Two cases of diabetic ketoacidosis in HNF1A-MODY linked to severe dehydration: Is it time to change the diagnostic criteria for MODY?. Diabetes Care 2013; 36: 2573-2574
• 7 Egan AM, Cunningham A, Jafar-Mohammadi B. et al. Diabetic ketoacidosis in the setting of HNF1A-maturity onset diabetes of the young. BMJ Case Rep 2015; 2015: bcr2014209163
• 8 Tang J, Tang CY, Wang F. et al. Genetic diagnosis and treatment of a Chinese ketosis-prone MODY 3 family with depression. Diabetol Metab Syndr 2017; 9: 5
• 9 Phan F, Bourron O, Laroche S. et al. Euglycaemic diabetic ketosis decompensation under dapagliflozin in a patient with MODY3. Diabetes Metab 2021; 47: 101248
• 10 Motyka R, Kołbuc M, Wierzchołowski W. et al. Four cases of maturity onset diabetes of the young (MODY) type 5 associated with mutations in the hepatocyte nuclear factor 1 beta (HNF1B) gene presenting in a 13-year-old boy and in adult men aged 33, 34, and 35 years in Poland. Am J Case Rep 2021; 22: e928994
• 11 Cheng Y, Zhong DP, Ren L. et al. Unusual manifestations of young woman with MODY5 based on 17q12 recurrent deletion syndrome. BMC Endocr Disord 2022; 22: 77
• 12 Hayakawa-Iwamoto A, Aotani D, Shimizu Y. et al. Maturity-onset diabetes of the young type 5, presenting as diabetic ketoacidosis with alkalemia: A report of a case. J Diabetes Investig 2022; 13: 923-926
• 13 Ge S, Yang M, Gong W. et al. Case Report: A case of HNF1B mutation patient with first presentation of diabetic ketosis. Front Endocrinol (Lausanne) 2022; 13: 917819
• 14 Xin S, Zhang X. Case Report: Diabetes mellitus type MODY5 as a feature of 17q12 deletion syndrome with diabetic gastroparesis. Front Endocrinol (Lausanne) 2023; 14: 1205431
• 15 Horikawa Y, Enya M, Mabe H. et al. NEUROD1-deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical features. Pediatr Diabetes 2018; 19: 236-242
• 16 Kondoh T, Nakajima Y, Yokoi K. et al. Identification of a novel mutation in carboxyl ester lipase gene in a patient with MODY-like diabetes. Tohoku J Exp Med 2022; 256: 37-41
• 17 Zhang D, Chen C, Yang W. et al. C.487C>T mutation in PAX4 gene causes MODY9: A case report and literature review. Medicine (Baltimore) 2022; 101: e32461
• 18 Johnson SR, McGown I, Oppermann U. et al. A novel INS mutation in a family with maturity-onset diabetes of the young: Variable insulin secretion and putative mechanisms. Pediatr Diabetes 2018; 19: 905-909
• 19 Li J, Wang X, Mao H. et al. Precision therapy for three Chinese families with maturity-onset diabetes of the young (MODY12). Front Endocrinol (Lausanne) 2022; 13: 858096
• 20 Chen C, Piao Y, Sang Y. A synonymous KCNJ11 variant leading to MODY13: A case report and literature review. Mol Genet Metab Rep 2023; 38: 101043
• 21 Kadota-Shinozaki A, Nakamura T, Hidaka H. et al. Diabetic lipemia with maturity-onset diabetes of the young. Intern Med 1997; 36: 571-574
• 22 Harms M, Stegemann B, Beier B. et al. Diabetic ketoacidosis in a female patient with HNF4A-MODY. Diabetol Stoffwechs 2024; 19: 214-217
• 23 Gardner DS, Tai ES. Clinical features and treatment of maturity onset diabetes of the young (MODY). Diabetes Metab Syndr Obes 2012; 5: 101-108
• 24 Isomaa B, Henricsson M, Lehto M. et al. Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia 1998; 41: 467-473
• 25 Steele AM, Shields BM, Shepherd M. et al. Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene. Diabet Med 2010; 27: 157-161
• 26 Greeley SAW, Polak M, Njølstad PR. et al. ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2022; 23: 1188-1211
• 27 Pleus S, Tytko A, Landgraf R. et al. Definition, classification, diagnosis and differential diagnosis of diabetes mellitus: Update 2023. Diabetol Stoffwechs 2023; 18: S100-S113
• 28 Shand JAD, Morrow P, Braatvedt G. Mortality after discharge from hospital following an episode of diabetic ketoacidosis. Acta Diabetol 2022; 59: 1485-1492